Peer-influenced content. Sources you trust. No registration required. This is HCN.

Mount SinaiMount Sinai Study Identifies New Gene That Drives Colon Cancer

The “super enhancer,” a complex region of DNA with a lot of transcriptional machinery that determines whether a cell is malignant, can be programmed by the environment around a colon cancer tumor for the first time, according to research. The PDZK1IP1 gene, which was not previously recognized as a cancer gene, is controlled by this super enhancer, which is the biggest 1-2% of all enhancers in the cell. Colon cancer growth was inhibited when PDZK1IP1 was deleted, indicating that PDZK1IP1 and its super enhancer may be targets for cancer treatments.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form